• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Adagio Medical Holdings Inc

    4/2/26 4:40:09 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care
    Get the next $ADGM alert in real time by email
    S-8 POS 1 tm2611014d1_s8pos.htm S-8 POS

      

    As filed with the Securities and Exchange Commission on April 2, 2026

     

    Registration No. 333-294719

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    POST-EFFECTIVE AMENDMENT NO. 1 TO

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

    Adagio Medical Holdings, Inc.

    (Exact name of Registrant as specified in its charter)

     

         
    Delaware   99-1151466

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification Number)

       

    26051 Merit Circle, Suite 102

    Laguna Hills, California

      92653
    (Address of Principal Executive Offices)   (Zip Code)

     

    Adagio Medical Holdings, Inc. 2024 Equity Incentive Plan

    (Full Title of the Plans)

     

    Todd Usen

    Chief Executive Officer

    Adagio Medical Holdings, Inc.

    26051 Merit Circle, Suite 102

    Laguna Hills, California 92653

    (949) 348-1188

    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

    Copies to:

     

    Eric Blanchard

    Paul Alexander

    Cooley LLP

    500 Boylston Street, 14th Floor

    Boston, MA 02116

    Tel: (617) 937-2300  

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨   Accelerated filer   ¨
    Non-accelerated filer x   Smaller reporting company   x
          Emerging growth company   x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 (File No. 333-294719), originally filed by Adagio Medical Holdings, Inc. (the "Registrant") with the Securities and Exchange Commission on March 30, 2026, is being filed solely to correct Exhibit 23.1, the Consent of Independent Registered Public Accounting Firm. The original filing mistakenly included a version of the consent with an incorrect date for the report of WithumSmith + Brown, PC with respect to the Registrant’s consolidated financial statements included in the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2025. No other changes have been made to the Registration Statement.

     

     

     

     

    Item 8. Exhibits.

     

    Reference is made under this Item 8 to the exhibit index included in this Registration Statement.

     

    Exhibit Index

     

    Exhibit
    Number
      Exhibit Description
         
    4.1   Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Commission on August 6, 2024).
         
    4.2   Amended and Restated By-Laws of the Registrant (incorporated herein by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed with the Commission on August 6, 2024).
       
    4.3   Specimen Common Stock Certificate of Registrant (incorporated herein by reference to Exhibit 4.4 to the Registrant’s Current Report on Form 8-K filed with the Commission on August 6, 2024).
         
    4.4   Registrant's 2024 Equity Incentive Plan (incorporated herein by reference to Exhibit 10.5 to the Registrant’s Current Report on Form 8-K filed with the Commission on August 6, 2024).
         
    5.1   Opinion of Cooley LLP (incorporated herein by reference to Exhibit 5.1 to the Registrant's Registration Statement on Form S-8 filed with the Commission on March 30, 2026).
       
    23.1*   Consent of WithumSmith+Brown, PC, independent registered public accounting firm for Adagio Medical Holdings, Inc.
       
    23.2   Consent of Cooley LLP (included as part of Exhibit 5.1) (incorporated herein by reference to Exhibit 23.2 to the Registrant's Registration Statement on Form S-8 filed with the Commission on March 30, 2026).
       
    24.1   Power of Attorney (included on the signature page hereto) (incorporated herein by reference to Exhibit 24.1 to the Registrant's Registration Statement on Form S-8 filed with the Commission on March 30, 2026).
       
    107   Filing Fee Table (incorporated herein by reference to Exhibit 107 to the Registrant's Registration Statement on Form S-8 filed with the Commission on March 30, 2026).

     

    * Filed herewith.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Laguna Hills, State of California, on this 2nd day of April, 2026.

     

      Adagio Medical Holdings, Inc.  
         
    By: /s/ Todd Usen  
      Todd Usen  
      Chief Executive Officer  

     

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

     

    Signature   Title   Date
             

     

    /s/ Todd Usen

     

    Chief Executive Officer and Director

    (Principal Executive Officer)

      April 2, 2026
    Todd Usen        
             
    /s/ Deborah Kaster   Chief Financial Officer   April 2, 2026
    Deborah Kaster   (Principal Financial and Accounting Officer)    
             
    *   Director   April 2, 2026
    James L. Cox        
             
    *   Director   April 2, 2026
    Orly Mishan        
             
    *   Director   April 2, 2026
    Keyvan Mirsaeedi-Farahani         
             
    *   Director   April 2, 2026
    Sean Salmon        
             
    *   Director   April 2, 2026
    Timothy Moran        
             
    *   Director   April 2, 2026
    Sandra Gardiner        
             
    /s/ Todd Usen        
    Todd Usen        
    Attorney-in-fact        

     

     

     

    Get the next $ADGM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADGM

    DatePrice TargetRatingAnalyst
    12/2/2025$4.00Buy
    Lake Street
    More analyst ratings

    $ADGM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Kaster Deborah

    4 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

    3/9/26 6:04:31 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Executive Officer Usen Todd

    4 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

    3/9/26 6:00:46 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Kaster Deborah bought $17,973 worth of shares (15,000 units at $1.20) (SEC Form 4)

    4 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

    12/18/25 6:00:11 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    $ADGM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026

    Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the pivotal results from the FULCRUM-VT study have been accepted for presentation in a late-breaking clinical science session at Heart Rhythm 2026 (HRS), the annual meeting of the Heart Rhythm Society. This is the first Investigational Device Exemption (IDE) study powered to evaluate the safety and effectiveness of Ultra-Low Temperature Ablation ("ULTA", formerly "ULTC") for the treatment of scar-related ventricular tachycardia (VT) in both ischemic and non-ischemic population. "Having FULCRUM-VT data

    4/1/26 8:00:00 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    Adagio Medical Reports Fourth Quarter and Full Year 2025 Results

    Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the fourth quarter ended December 31, 2025. Fourth Quarter and Recent Business Highlights: Announced the peer-reviewed publication in Circulation: Arrythmia and Electrophysiology, highlighting results from the U.S. Early Feasibility Study evaluating ultralow temperature cardiac ablation ("ULTA") for the treatment of scar-related ventricular tachycardia ("VT"), which demonstrated a favorable safety profile and no device- or procedure-related major adverse events in a real-world patie

    3/27/26 8:00:00 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter

    Highlights Improvements in Next Generation ULTA Catheter, Including Potential 50-75% Reduction in Ablation Time Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication of pre-clinical results of the Company's next generation ultra-low temperature ablation ("ULTA") technology designed to treat ventricular arrhythmias. The publication, which is titled "Initial Pre‐Clinical Evaluation of the Augmented Ultra‐Low Temperature Cryoablation Catheter for Ventricular Ablation" was published in the Journal of Cardiovascular Electrophysiology and describes s

    3/24/26 8:00:00 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    $ADGM
    SEC Filings

    View All

    SEC Form S-8 POS filed by Adagio Medical Holdings Inc

    S-8 POS - Adagio Medical Holdings, Inc. (0002006986) (Filer)

    4/2/26 4:40:09 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    SEC Form POS AM filed by Adagio Medical Holdings Inc

    POS AM - Adagio Medical Holdings, Inc. (0002006986) (Filer)

    4/2/26 4:37:53 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    SEC Form POS AM filed by Adagio Medical Holdings Inc

    POS AM - Adagio Medical Holdings, Inc. (0002006986) (Filer)

    4/2/26 4:36:34 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    $ADGM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Adagio Medical Holdings with a new price target

    Lake Street initiated coverage of Adagio Medical Holdings with a rating of Buy and set a new price target of $4.00

    12/2/25 8:38:52 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    $ADGM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Kaster Deborah bought $17,973 worth of shares (15,000 units at $1.20) (SEC Form 4)

    4 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

    12/18/25 6:00:11 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Usen Todd bought $225,973 worth of shares (207,315 units at $1.09) (SEC Form 4)

    4 - Adagio Medical Holdings, Inc. (0002006986) (Issuer)

    12/15/25 9:24:15 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    $ADGM
    Leadership Updates

    Live Leadership Updates

    View All

    Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness

    Marie-Claude Jacques appointed Senior Vice President, Global Sales; Antwan Gipson joins as Senior Vice President, Manufacturing & Operations Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced two key additions to its senior leadership team: Marie-Claude Jacques as Senior Vice President, Global Sales and Antwan Gipson as Senior Vice President, Manufacturing and Operations. "These appointments represent a significant milestone as Adagio prepares for commercialization of our proprietary Ultra-Low Temperature Cardiac Ablation technology ("ULTC") for electrophys

    12/22/25 8:00:00 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors

    Adagio Medical Holdings, Inc (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon has been appointed to its Board of Directors. Mr. Salmon will also serve on the Company's Audit Committee and Compensation Committee. Mr. Salmon, 60, recently retired from Medtronic after a distinguished, 20+ year tenure during which he held multiple senior global leadership roles across the company's cardiovascular and diabetes businesses. Most recently, he served as Executive Vice President and President of Medtronic's Cardiovascular Portfolio, which includes the Cardiac Rhythm, Cardiac Abl

    12/11/25 8:00:00 AM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    Adagio Medical Reports Third Quarter 2025 Results

    Continued Momentum Toward PMA Submission of ULTC Technologies Recent Financing Positions Company to Execute Growth Strategy Adagio Medical Holdings, Inc (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the third quarter ended September 30, 2025. Recent Business Highlights: Closed a private placement on October 20, 2025, with gross proceeds of up to $50 million, led by a syndicate of healthcare-dedicated institutional investors; upfront proceeds of approximately $19 million expected to fund FDA submission activities and ongoing next generation catheter deve

    11/12/25 4:05:00 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    $ADGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Adagio Medical Holdings Inc

    SC 13G - Adagio Medical Holdings, Inc. (0002006986) (Subject)

    11/13/24 4:30:17 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Adagio Medical Holdings Inc

    SC 13G - Adagio Medical Holdings, Inc. (0002006986) (Subject)

    8/12/24 4:22:57 PM ET
    $ADGM
    Medical/Dental Instruments
    Health Care